BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25452756)

  • 41. Rituximab in ANCA-associated vasculitis: fad or fact?
    Fervenza FC
    Nephron Clin Pract; 2011; 118(2):c182-8; discussion c188. PubMed ID: 21160229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary vasculitis.
    Lally L; Spiera RF
    Rheum Dis Clin North Am; 2015 May; 41(2):315-31. PubMed ID: 25836645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.
    Berti A; Cavalli G; Campochiaro C; Guglielmi B; Baldissera E; Cappio S; Sabbadini MG; Doglioni C; Dagna L
    Semin Arthritis Rheum; 2015 Aug; 45(1):48-54. PubMed ID: 25841802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art.
    Vaglio A; Buzio C; Zwerina J
    Allergy; 2013 Mar; 68(3):261-73. PubMed ID: 23330816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Granulomatous vasculitis.
    Marzano AV; Balice Y; Tavecchio S; Desimine C; Colombo A; Berti E
    G Ital Dermatol Venereol; 2015 Apr; 150(2):193-202. PubMed ID: 25791629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis.
    Uribe AG; Huber AM; Kim S; O'Neil KM; Wahezi DM; Abramson L; Baszis K; Benseler SM; Bowyer SL; Campillo S; Chira P; Hersh AO; Higgins GC; Eberhard A; Ede K; Imundo LF; Jung L; Kingsbury DJ; Klein-Gitelman M; Lawson EF; Li SC; Lovell DJ; Mason T; McCurdy D; Muscal E; Nassi L; Rabinovich E; Reiff A; Rosenkranz M; Schikler KN; Singer NG; Spalding S; Stevens AM; Cabral DA;
    J Rheumatol; 2012 Aug; 39(8):1687-97. PubMed ID: 22589257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA genes in ANCA-associated vasculitides.
    Griffith ME; Pusey CD
    Exp Clin Immunogenet; 1997; 14(3):196-205. PubMed ID: 9493788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature.
    Rothschild PR; Pagnoux C; Seror R; Brézin AP; Delair E; Guillevin L
    Semin Arthritis Rheum; 2013 Apr; 42(5):507-14. PubMed ID: 23270762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ANCA-associated small-vessel vasculitis.
    Mansi IA; Opran A; Rosner F
    Am Fam Physician; 2002 Apr; 65(8):1615-20. PubMed ID: 11989638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis).
    Lutalo PM; D'Cruz DP
    J Autoimmun; 2014; 48-49():94-8. PubMed ID: 24485158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The environment, geoepidemiology and ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Autoimmun Rev; 2010 Mar; 9(5):A293-8. PubMed ID: 19892038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study.
    Arulkumaran N; Periselneris N; Gaskin G; Strickland N; Ind PW; Pusey CD; Salama AD
    Rheumatology (Oxford); 2011 Nov; 50(11):2035-43. PubMed ID: 21873269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis.
    Sinico RA; Di Toma L; Radice A
    Autoimmun Rev; 2013 Feb; 12(4):477-82. PubMed ID: 22921791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
    Kallenberg CG; Heeringa P; Stegeman CA
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases.
    Kumar V; Wijmenga C; Withoff S
    Semin Immunopathol; 2012 Jul; 34(4):567-80. PubMed ID: 22580835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine.
    Yap BJM; Lai-Foenander AS; Goh BH; Ong YS; Duangjai A; Saokaew S; Chua CLL; Phisalprapa P; Yap WH
    Front Cardiovasc Med; 2021; 8():732369. PubMed ID: 34621800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leveraging Genetic Findings for Precision Medicine in Vasculitis.
    Acosta-Herrera M; González-Gay MA; Martín J; Márquez A
    Front Immunol; 2019; 10():1796. PubMed ID: 31428096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Churg-Strauss syndrome.
    Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
    Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.
    Schönermarck U; Csernok E; Gross WL
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i46-52. PubMed ID: 25540095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Alberici F; Martorana D; Vaglio A
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i37-45. PubMed ID: 25523449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.